Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

Author: SHIFAMED, LLC / SPRIG CONSULTING, LLC

Posted Date: